RAD23A

Across TCGA pan-cancer cohorts, RAD23A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RAD23A data layer compared with 27 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RAD23A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAD23A expression acts as an unfavorable survival marker.

OV, UCEC, and ACC are the cancer types where RAD23A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	All	0.064	0.541	<.001	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
ACC	DFS	Median	All	0.140	0.666	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RAD23A–OV (DFS)

Open the OV breakdown →